Trial
NCT01885949
Tivozanib + Enzalutamide in Adv Prostate Cancer
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Massachusetts General Hospital
Collaborators
National Comprehensive Cancer Network
Condition
Prostate Cancer
Intervention
Tivozanib
Why stopped
Slow accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-05-20